A citation-based method for searching scientific literature

David Rodbard. Diabetes Technol Ther 2018
Times Cited: 52







List of co-cited articles
312 articles co-cited >1



Times Cited
  Times     Co-cited
Similarity


International Consensus on Use of Continuous Glucose Monitoring.
Thomas Danne, Revital Nimri, Tadej Battelino, Richard M Bergenstal, Kelly L Close, J Hans DeVries, Satish Garg, Lutz Heinemann, Irl Hirsch, Stephanie A Amiel,[...]. Diabetes Care 2017
728
53

Clinical Targets for Continuous Glucose Monitoring Data Interpretation: Recommendations From the International Consensus on Time in Range.
Tadej Battelino, Thomas Danne, Richard M Bergenstal, Stephanie A Amiel, Roy Beck, Torben Biester, Emanuele Bosi, Bruce A Buckingham, William T Cefalu, Kelly L Close,[...]. Diabetes Care 2019
872
36

Toward Defining the Threshold Between Low and High Glucose Variability in Diabetes.
Louis Monnier, Claude Colette, Anne Wojtusciszyn, Sylvie Dejager, Eric Renard, Nicolas Molinari, David R Owens. Diabetes Care 2017
153
26

Glycaemic variability in diabetes: clinical and therapeutic implications.
Antonio Ceriello, Louis Monnier, David Owens. Lancet Diabetes Endocrinol 2019
178
26

The Relationships Between Time in Range, Hyperglycemia Metrics, and HbA1c.
Roy W Beck, Richard M Bergenstal, Peiyao Cheng, Craig Kollman, Anders L Carlson, Mary L Johnson, David Rodbard. J Diabetes Sci Technol 2019
146
21

Glucose Management Indicator (GMI): A New Term for Estimating A1C From Continuous Glucose Monitoring.
Richard M Bergenstal, Roy W Beck, Kelly L Close, George Grunberger, David B Sacks, Aaron Kowalski, Adam S Brown, Lutz Heinemann, Grazia Aleppo, Donna B Ryan,[...]. Diabetes Care 2018
187
19

The Relationship of Hemoglobin A1C to Time-in-Range in Patients with Diabetes.
Robert A Vigersky, Chantal McMahon. Diabetes Technol Ther 2019
146
19



Activation of oxidative stress by acute glucose fluctuations compared with sustained chronic hyperglycemia in patients with type 2 diabetes.
Louis Monnier, Emilie Mas, Christine Ginet, Françoise Michel, Laetitia Villon, Jean-Paul Cristol, Claude Colette. JAMA 2006
17



Effect of Continuous Glucose Monitoring on Glycemic Control in Adults With Type 1 Diabetes Using Insulin Injections: The DIAMOND Randomized Clinical Trial.
Roy W Beck, Tonya Riddlesworth, Katrina Ruedy, Andrew Ahmann, Richard Bergenstal, Stacie Haller, Craig Kollman, Davida Kruger, Janet B McGill, William Polonsky,[...]. JAMA 2017
489
13

Glycemic Variability Percentage: A Novel Method for Assessing Glycemic Variability from Continuous Glucose Monitor Data.
Thomas A Peyser, Andrew K Balo, Bruce A Buckingham, Irl B Hirsch, Arturo Garcia. Diabetes Technol Ther 2018
41
17

Recommendations for standardizing glucose reporting and analysis to optimize clinical decision making in diabetes: the Ambulatory Glucose Profile (AGP).
Richard M Bergenstal, Andrew J Ahmann, Timothy Bailey, Roy W Beck, Joan Bissen, Bruce Buckingham, Larry Deeb, Robert H Dolin, Satish K Garg, Robin Goland,[...]. Diabetes Technol Ther 2013
159
13

Long-term Glycemic Variability and Risk of Adverse Outcomes: A Systematic Review and Meta-analysis.
Catherine Gorst, Chun Shing Kwok, Saadia Aslam, Iain Buchan, Evangelos Kontopantelis, Phyo K Myint, Grant Heatlie, Yoon Loke, Martin K Rutter, Mamas A Mamas. Diabetes Care 2015
249
13


Association of Time in Range, as Assessed by Continuous Glucose Monitoring, With Diabetic Retinopathy in Type 2 Diabetes.
Jingyi Lu, Xiaojing Ma, Jian Zhou, Lei Zhang, Yifei Mo, Lingwen Ying, Wei Lu, Wei Zhu, Yuqian Bao, Robert A Vigersky,[...]. Diabetes Care 2018
177
13

Ambulatory glucose profile: representation of verified self-monitored blood glucose data.
R S Mazze, D Lucido, O Langer, K Hartmann, D Rodbard. Diabetes Care 1987
94
13


Validation of Time in Range as an Outcome Measure for Diabetes Clinical Trials.
Roy W Beck, Richard M Bergenstal, Tonya D Riddlesworth, Craig Kollman, Zhaomian Li, Adam S Brown, Kelly L Close. Diabetes Care 2019
258
13

Beyond HbA1c: Comparing Glycemic Variability and Glycemic Indices in Predicting Hypoglycemia in Type 1 and Type 2 Diabetes.
Suresh Rama Chandran, Wei Lin Tay, Weng Kit Lye, Lee Ling Lim, Jeyakantha Ratnasingam, Alexander Tong Boon Tan, Daphne S L Gardner. Diabetes Technol Ther 2018
49
14

Q-Score: development of a new metric for continuous glucose monitoring that enables stratification of antihyperglycaemic therapies.
Petra Augstein, Peter Heinke, Lutz Vogt, Roberto Vogt, Christine Rackow, Klaus-Dieter Kohnert, Eckhard Salzsieder. BMC Endocr Disord 2015
28
25

Mean amplitude of glycemic excursions, a measure of diabetic instability.
F J Service, G D Molnar, J W Rosevear, E Ackerman, L C Gatewood, W F Taylor. Diabetes 1970
844
13

The application of simple metrics in the assessment of glycaemic variability.
L Monnier, C Colette, D R Owens. Diabetes Metab 2018
46
15

Optimal Sampling Duration for Continuous Glucose Monitoring to Determine Long-Term Glycemic Control.
Tonya D Riddlesworth, Roy W Beck, Robin L Gal, Crystal G Connor, Richard M Bergenstal, Sooji Lee, Steven M Willi. Diabetes Technol Ther 2018
91
11


A novel approach to continuous glucose analysis utilizing glycemic variation.
C M McDonnell, S M Donath, S I Vidmar, G A Werther, F J Cameron. Diabetes Technol Ther 2005
226
11

Oscillating glucose is more deleterious to endothelial function and oxidative stress than mean glucose in normal and type 2 diabetic patients.
Antonio Ceriello, Katherine Esposito, Ludovica Piconi, Michael A Ihnat, Jessica E Thorpe, Roberto Testa, Massimo Boemi, Dario Giugliano. Diabetes 2008
758
11

Day-to-day fasting glycaemic variability in DEVOTE: associations with severe hypoglycaemia and cardiovascular outcomes (DEVOTE 2).
Bernard Zinman, Steven P Marso, Neil R Poulter, Scott S Emerson, Thomas R Pieber, Richard E Pratley, Martin Lange, Kirstine Brown-Frandsen, Alan Moses, Ann Marie Ocampo Francisco,[...]. Diabetologia 2018
90
11

Impact of visit-to-visit glycemic variability on the risks of macrovascular and microvascular events and all-cause mortality in type 2 diabetes: the ADVANCE trial.
Yoichiro Hirakawa, Hisatomi Arima, Sophia Zoungas, Toshiharu Ninomiya, Mark Cooper, Pavel Hamet, Giuseppe Mancia, Neil Poulter, Stephen Harrap, Mark Woodward,[...]. Diabetes Care 2014
194
11

10-year follow-up of intensive glucose control in type 2 diabetes.
Rury R Holman, Sanjoy K Paul, M Angelyn Bethel, David R Matthews, H Andrew W Neil. N Engl J Med 2008
11

Glucose variability.
F John Service. Diabetes 2013
129
11


The Comprehensive Glucose Pentagon: A Glucose-Centric Composite Metric for Assessing Glycemic Control in Persons With Diabetes.
Robert A Vigersky, John Shin, Boyi Jiang, Thorsten Siegmund, Chantal McMahon, Andreas Thomas. J Diabetes Sci Technol 2018
23
26

A method for assessing quality of control from glucose profiles.
N R Hill, P C Hindmarsh, R J Stevens, I M Stratton, J C Levy, D R Matthews. Diabet Med 2007
87
11

Normal reference range for mean tissue glucose and glycemic variability derived from continuous glucose monitoring for subjects without diabetes in different ethnic groups.
Nathan R Hill, Nick S Oliver, Pratik Choudhary, Jonathan C Levy, Peter Hindmarsh, David R Matthews. Diabetes Technol Ther 2011
192
11

Continuous Glucose Monitoring vs Conventional Therapy for Glycemic Control in Adults With Type 1 Diabetes Treated With Multiple Daily Insulin Injections: The GOLD Randomized Clinical Trial.
Marcus Lind, William Polonsky, Irl B Hirsch, Tim Heise, Jan Bolinder, Sofia Dahlqvist, Erik Schwarz, Arndís Finna Ólafsdóttir, Anders Frid, Hans Wedel,[...]. JAMA 2017
307
9

The contribution of glucose variability to asymptomatic hypoglycemia in persons with type 2 diabetes.
Louis Monnier, Anne Wojtusciszyn, Claude Colette, David Owens. Diabetes Technol Ther 2011
113
9

Glucose variability is associated with intensive care unit mortality.
Jeroen Hermanides, Titia M Vriesendorp, Robert J Bosman, Durk F Zandstra, Joost B Hoekstra, J Hans Devries. Crit Care Med 2010
288
9

Association of Glycemic Variability in Type 1 Diabetes With Progression of Microvascular Outcomes in the Diabetes Control and Complications Trial.
John M Lachin, Ionut Bebu, Richard M Bergenstal, Rodica Pop-Busui, F John Service, Bernard Zinman, David M Nathan. Diabetes Care 2017
92
9

The Fallacy of Average: How Using HbA1c Alone to Assess Glycemic Control Can Be Misleading.
Roy W Beck, Crystal G Connor, Deborah M Mullen, David M Wesley, Richard M Bergenstal. Diabetes Care 2017
181
9

Measures of Glycemic Variability in Type 1 Diabetes and the Effect of Real-Time Continuous Glucose Monitoring.
Ahmed H El-Laboudi, Ian F Godsland, Desmond G Johnston, Nick S Oliver. Diabetes Technol Ther 2016
43
11



THE M-VALVE, AN INDEX OF BLOOD-SUGAR CONTROL IN DIABETICS.
J SCHLICHTKRULL, O MUNCK, M JERSILD. Acta Med Scand 1965
380
9

Evaluating Glucose Control With a Novel Composite Continuous Glucose Monitoring Index.
Lalantha Leelarathna, Hood Thabit, Malgorzata E Wilinska, Lia Bally, Julia K Mader, Thomas R Pieber, Carsten Benesch, Sabine Arnolds, Terri Johnson, Lutz Heinemann,[...]. J Diabetes Sci Technol 2020
15
33

Glucose variability; does it matter?
Sarah E Siegelaar, Frits Holleman, Joost B L Hoekstra, J Hans DeVries. Endocr Rev 2010
284
9

Defining High Glycemic Variability in Type 1 Diabetes: Comparison of Multiple Indexes to Identify Patients at Risk of Hypoglycemia.
Ana María Gómez, Diana Cristina Henao, Angélica Imitola Madero, Lucía B Taboada, Viviana Cruz, María Alejandra Robledo Gómez, Martin Rondón, Oscar Muñoz-Velandia, Maira García-Jaramillo, Fabian Mauricio León Vargas. Diabetes Technol Ther 2019
20
25



Co-cited is the co-citation frequency, indicating how many articles cite the article together with the query article. Similarity is the co-citation as percentage of the times cited of the query article or the article in the search results, whichever is the lowest. These numbers are calculated for the last 100 citations when articles are cited more than 100 times.